Evan Loh, Director at Eiger BioPharmaceuticals, Inc. (EIGR), sold 2,000 shares at $10.14 ($20K) on 2021-03-15, disclosed to the SEC on 2021-03-15.
Open-market sale of $20k EIGR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |